Furthermore, upregulation of proinflammatory cytokines, acute phase proteins, and VEGF and downregulation of protective anti-inflammatory mediators was pronounced in patients with low SMA and high visceral to total fat ratio who experienced poor clinical or cancer outcomes. The gene discussed is SMN1; the disease is cancer.